An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users

NCT06097676 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Abuse Potential

Interventions

DRUG: Placebo
DRUG: Alprazolam 2 mg
DRUG: Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg
DRUG: Gabapentin Enacarbil Immediate Release (GE-IR) 450 mg
DRUG: Gabapentin Enacarbil Immediate Release (GE-IR) 700 mg

Sponsor

Arbor Pharmaceuticals, Inc.